Sero-prevalence study of parasitic infections among HIV positive and Negative patients in Lagos, Nigeria by Sanyaolu, AO et al.
88 
 
ORIGINAL ARTICLE     
AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY   MAY 2016   ISBN 1595-689X VOL17 No.2                                                             
AJCEM/1612                                                                                                                                COPYRIGHT 2016                                                                                 
AFR. J. CLN. EXPER. MICROBIOL. 17 (2): 88-96http://dx.doi.org/10.4314/ajcem.v17i2.3  
                
SERO-PREVALENCE STUDY OF PARASITIC INFECTIONS AMONG HIV POSITIVE AND 
NEGATIVE PATIENTS IN LAGOS, NIGERIA 
¹Sanyaolu, A.O., ²Oyibo, W.A., ²Iriemenam, N.C., 3Badaru, O.S. 
1. Department of Medical Microbiology & Immunology, St. James School of Medicine, Anguilla, BWI; 
 2. Department of Medical Microbiology & Parasitology, College of Medicine of the University of Lagos, Idi-
araba, Lagos, Nigeria; 3. National Center for Disease Control, Federal Ministry of Health, Abuja, Nigeria 
Correspondence: Dr. Adekunle O. Sanyaolu, Department of Medical Microbiology and Immunology, St. James 
School of Medicine, Albert Lake Dr. The Quarter, P.O. Box 318. The Valley, Anguilla, BWI. Email: 
sanyakunle@gmail.com  
ABSTRACT                                                                                                                                                               
Background: Diseases caused by opportunistic pathogens are the major clinical signs of HIV infected 
and AIDS patients with parasitic infection being part of the common causes of morbidity and mortality. 
Objectives: This was a cross-sectional study to determine the sero-prevalence of serum antibodies to 
three parasitic infections namely Entamoeba histolytica, Schistosoma sp. and Toxoplasma gondii, which 
are opportunistic infections among HIV/AIDS patients.  
Methods: One thousand and eighty patients that attended three healthcare institutions in Lagos were 
recruited for the study through convenience sampling method. Venous blood was collected from the 
recruited patients and screened for HIV infection as well as the presence of serum antibodies to three 
parasitic infections. All positive sera samples were confirmed for HIV infection. 
Result: The results revealed that 65/1080 (6%) of the recruited patients were HIV sero-positive. In 
addition, 5/65 (7.7%) of the HIV positive patients had E. histolytica co-infection, 1/65 (1.5%) had 
Schistosoma sp. co-infection while 2/65 (3.1%) had T. gondii co-infection. The results also indicated that 
the proportion of patients with E. histolytica was significantly higher among HIV sero-positive patients 
than the sero-negative patients (P = 0.031).  
Conclusion: The study showed the opportunistic potential of the three parasitic infections among 
HIV/AIDS patients in the study area. 
Keywords: [HIV, AIDS, Seropositive, Seronegative, Toxoplasma gondii, Entamoeba histolytica, 
Schistosoma haematobium} 
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RÉSUMÉ                                                                                                                                                                                             
CONTEXTE : Les maladies causées par les pathogènes opportunistes sont les principaux signes cliniques des patients 
infectés par le VIH et des  Patients infectés par le VIH et le SIDA avec les infections parasitaires faisant partie des 
causes fréquentes de morbidité et de mortalité. 
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OBJECTIFS : Ceci fut une étude transversale pour déterminer la séroprévalence des anticorps sériques aux trois 
infections parasitaires à savoir Entamoeba histolytica, Schistosoma sp. et Toxoplasma gondii, qui sont les infections 
opportunistes chez les patients VIH/SIDA. 
METHODES : Mille huit cent patients qui ont à trois établissements de sante à Lagos ont été recrutés pour l’étude à 
travers la méthode d’échantillonnage de commodité. Sang veineux a été recueilli des patients recrutés et dépistés pour 
les infections du VIH ainsi que la présence des anticorps sériques aux trois infections parasitaires. Tous les 
échantillons de sérums positifs ont été confirmés pour l’infection au VIH. 
RESULTAT : Les résultats ont montré que des patients 65 sur 1 080 (6%) recrutésétaientséropositifs pour le VIH. En 
outre, 5 sur 65(7,7%) des patients séropositifs avaient l’infection E.histolytica,1 sur 65 (1,5%) avait la coinfection 
Schistosoma sp.alors que 2 sur 65(3,1%) avaient la coinfection T.gondii. Les résultats ont également indiqué que la 
proportion de patients avec E.histolytica était significativement plus élevée chez les patients VIH séropositifs que les 
patients séronégatifs (P=0,031). 
CONCLUSION : L’étude a montré le potentiel opportuniste des trois infections parasitaires chez les patients 
VIH/SIDA dans la zone d’étude. 
MOTS CLES : {VIH,SIDA, Seropositif, Seronegatif, Toxoplasma gondii, Entamoeba histolytica, Schistosoma 
haematobium} 
INTRODUCTION                                                            
Infections caused by these parasites Toxoplasma 
gondii, Schistosoma sp. and Entamoeba histolytica 
have been characterized as opportunistic 
infection in human immunodeficiency virus 
(HIV) and acquired immunodeficiency syndrome 
(AIDS) patients around the world (1, 2, 3). The 
major clinical manifestation of HIV infection as 
well as in AIDS patients is diseases caused by 
opportunistic pathogens and parasitic co-
infections constituted part of the common causes 
of morbidity and mortality( 4, 5).  
Toxoplasmosis is a typical disease that affects 
humans, with most cases asymptomatic. While 
the prevalence of Toxoplasma antibodies 
correspond with age, it does not correspond with 
sex; variations and differences exist in each 
country. In part of sub-Saharan Africa with moist 
weather, variations in toxoplasmosis prevalence 
ranges between 50% and 70% and the estimated 
population risk and infection is one third and 
half among worldwide population (6). The 
incidence of sero-positivity varies in humans, 
showing previous exposure and location in 
addition to eating habits (7, 8). Previous studies 
demonstrated the common cause of focal lesions 
of the brain as a result of Toxoplasma encephalitis 
and thereby complicating the direction of AIDS 
due to the reactivation of a latent infection (9, 10). 
In advanced stage with Toxoplasma encephalitis 
recrudescent toxoplasmosis usually manifest as 
cerebral abscess impairing the immune responses 
to infections causing the infective reactivation in 
AIDS patients through immune suppression (2, 
11, 12). Patients with Toxoplasma and HIV co-
infections have between 30% to 40% risk of 
developing Toxoplasma encephalitis especially 
amongst those with significant 
immunosuppression (CD4 count less than 200 
cells/µl) (13). 
Schistosomiasis is a parasitic disease cause by 
Schistosoma sp. and it is mainly found in the 
tropical and sub-tropical areas of the world. Due 
to inadequate potable water supply and limited 
water resource development, schistosomiasis is 
prevalent in sub-Saharan Africa, Asia and South 
America (14). Earlier studies demonstrated that 
urinary schistosomiasis occurs more than 
intestinal schistosomiasis in Nigeria (15, 16). Both 
HIV/AIDS and schistosomiasis causes significant 
disease burden in sub-Saharan Africa with 
frequent overlap in their epidemiological 
characteristics17. While few studies have 
examined interaction between the two diseases 
(3, 15, 16, 17, 18, 19), studies have shown that 
both diseases exert bi-directional effects on one 
another (20, 21). 
Entamoeba histolytica primarily inhabits the large 
intestine where the trophozoites or active forms 
live. Studies have shown that morphologically 
identical pathogenic and non-pathogenic strains 
of amoebae that are genetically, biochemically 
and immunologically distinguishable exist (22, 
23, 24). However, the same strain can change its 
behavior within the same host from time to time. 
Hence, there is no doubt that 
immunosuppression of the host can turn a 
harmless commensal infection into a dangerously 
invasive one (1, 25, 26). Invasive amoebiasis (IA) 
is a significant parasitic infection that is 
associated with significant morbidity and 
mortality world-wide in individuals that resides 
or travels to endemic areas and it accounts for 
40,000 to 100,000 deaths annually. IA had 
previously been reported in HIV infected / AIDS 
patients (27, 28, 29, 30). 
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While some work had been conducted on these 
parasitic infections in Nigeria, few of such 
studies had been carried out comparatively in 
HIV infected and non-infected individuals in the 
country. Hence, the objective of this study was 
aimed at determining the sero-prevalence of 
these three parasitic infections among HIV 
seropositive and sero-negative patients using 
serodiagnostic approach to determine the 
presence of serum antbody to these infections. 
Research Method and Design                                  
Study design                                                                                     
This was a cross-sectional based study that was 
designed to carry out sero-prevalence of serum 
antibodies to three parasitic infections namely 
Entamoeba histolytica, Schistosoma sp. and 
Toxoplasma gondii using serodiagnostic approach. 
Details of the study design and population have 
been published previously31. Briefly, patients 
attending three health-care institutions in Lagos, 
Nigeria namely, General Hospital Ikeja, Sexually 
Transmitted Diseases Clinic Yaba, and the 
Central Public Health Laboratory Yaba were 
recruited for the study through the convenient 
sampling method between January 1996 and 
December 1997. The selected institutions serve as: 
(i) provider-based facility, (ii) referral centre for 
HIV and STD patients, and (iii) client based 
facility especially for people who intend to be 
familiar with their HIV and STD statuses.  
Blood samples for screening of HIV, Toxoplasma 
gondii, Schistosoma sp, and Entamoeba histolytica 
were obtained with consent from 1080 patients 
out of 200 patients interviewed. Written informed 
consent or thumbprints were received from all 
recruited individuals and consent could not be 
obtained from 920 patients who declined to 
participate and were excluded from the study. 
Both patients who refused to be recruited for the 
study and those who were sero-positive in the 
study were given adequate clinical services. 
Laboratory procedures                                                    
Blood sera of the patients were screened for HIV-
1 and HIV-2 using Cambridge Biotech 
Corporation Recombigen HIV-1 and HIV-2 rapid 
test device while confirmation of positive cases 
was done with Immunocomb 11 and Bio-rad 
Novapath HIV-1 immunoblot for HIV-2 and 
HIV-1, respectively. 
Diagnosis of parasitic infections from blood sera 
of sampled patients was done by Indirect 
Haemaglutination (IHA) method. The IHA 
principle involves the use of reagent made of 
formalized sheep blood cells, which are 
sensitized by a soluble antigen of the parasite and 
made to react with antibodies present in the 
patient with the formation of a 
haemagglutination i.e. a reddish-brown film that 
is observed in the wells of a U-microplate. In the 
absence of specific antibodies, the sensitized red 
blood cells will deposit, by forming a ring in the 
bottom of the well.  Cellognost® kits from 
Behring Diagnostic Inc. were used for the 
screening of IgG antibodies to Schistosoma sp. and 
Entamoeba histolytica, while Toxocell IHA kits 
from Biokit SA were used for screening of T. 
gondii IgG antibodies. Toxoplasma kits from 
Randox Laboratories Ltd. were used for the 
detection of IgM antibodies to T. gondii by the 
Enzyme Linked Immunosorbent Assay (ELISA) 
method. Titer values were interpreted specific to 
each parasite according to the manufacture’s 
guideline for interpretation as earlier 
documented (32, 33, 34, 35, 36, 37). 
Manufactures recommended cutoff titer of 1:16 
(Low) and 1:32 was used for the evaluation of 
Entamoeba histolytica and Schistosoma sp., while 
1:64 (Toxo IgG) and 0.9 (Toxo IgM) was used for 
Toxoplasma gondii 
Data analysis                                                                   
The obtained data were analyzed using the EPI-
INFO Statistical Package, version 6.0. Statistical 
significance of the proportions of categorical data 
was estimated using Fisher’s exact test for 
contingency table. All tests were two-tailed and 
P-value of <0.05 was taken as statistical 
significant.  
RESULTS                                                                                  
Of the sampled patients (aged 4 to 62 years), 
36/1080 (3.3%) were males and 29/1080 (2.7%) 
were females. Titer values ranged from 1:16 to 
1:4096. Out of the total patients screened for HIV 
in the study, 65 (6%) were sero-positive. Among 
the 65 patients with confirmed HIV sero-positive 
results, 8 (12.3%) had three parasitic co-infections 
while among the 1015 patients without HIV 
infections, 34 (3.3%) had the three infections 
(Table 1). 
Sero-diagnosis assay from the study showed that 
5 (7.7%) of patients with HIV sero-positive result 
had serum antibodies to E. histolytica (Table 1). 
Titer values of serum antibodies to E. histolytica 
infection ranged from 1:16 to 1:512 for the 
sampled patients. A significant titer value range 
of 1:32 to 1:512 was found in 5 (0.5%) HIV sero-
negative patients, while 3 (4.6%) HIV sero-
positive patients had a significant titer value of 




Only 4 (0.4%) HIV sero-negative patients and 1 
(1.5%) HIV sero-positive patients had serum 
antibodies to Schistosoma sp. infection (Table 1). 
Among HIV sero-negative patients 3 (0.3%) had a 
titer of 1:16 while only 1 (0.1%) patient had a 
higher titer of 1:256. Titer value in the HIV sero-
positive patient was 1:16 (Table 2). 
TABLE 1: SAMPLED PATIENTS WITH SERUM ANTIBODIES TO PARASITIC INFECTIONS 
Parasitic infection Patients with serum antibody Total 
HIV+ 
N = 65 (%) 
HIV- 
N = 1015 (%) 
 
N = 1080 (%) 
E. histolytica 5 (7.7) 24 (2.4)* 29 (2.7) 
Schistosoma sp. 1 (1.5)  4 (0.4)** 5 (0.5) 
T. gondii 2 (3.1) 6 (0.6)*** 8 (0.8) 
Total 8 (12.3) 34 (3.3)  
*P = 0.031, ** P = 0.27, ***P = 0.082 
Serum antibodies to T. gondii infection were 
found in 2 (3.1%) of HIV sero-positive patients 
and in 6 (0.6%) of the sero-negative patients with 
titer value range of 1:16 to 1: 128 (Table 1). 
Significant titer value of ≥ 1:64 Toxo kit and >0.9 
Toxo IgM kit interpretations was recorded in 1 
(0.1%) HIV sero-negative patient and 2 (3.1%) 
HIV sero-positive patients (Tables 2).  
Result from the study also showed that more 
patients within the age range 21-30 years in both 
HIV sero-positive and sero-negative patients had 
serum antibody to T. gondii infection (Table 3). 
Also, more females than males presented with 
antibodies to T. gondii infection in HIV sero-
positive 2 (3.1%) and HIV sero-negative 5 (0.5%) 
patients. (Table 4). 
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Sero-positive for invasive E. 
histolytica 
Sero-positive for Schistosoma 
sp. 
Sero-positive for T. gondii 
 HIV sero- HIV sero+ HIV sero- HIV sero+ HIV sero- HIV sero+ 
1-10 3 (0.3)      
11-20 5 (0.5) 1 (1.5) 2 (0.2)  1 (0.1)  
21-30 5 (0.5) 2 (3.1) 2 (0.2) 1 (1.5) 3 (0.3) 2 (3.1) 
31-40 6 (0.6) 2 (3.1)   2 (0.2)  
41-50 3 (0.3)      
>50 2 (0.2)      
 
TABLE 4: SEX DISTRIBUTION OF SAMPLED PATIENTS SHOWING SERO-POSITIVITY FOR PARASITIC 
INFECTIONS 
Sex Sero-positive for invasive E. 
histolytica 
Sero-positive for Schistosoma 
sp. 
Sero-positive for T. gondii 
 HIV sero- HIV sero+ HIV sero- HIV sero+ HIV sero- HIV sero+ 
Males 14 (1.4) 3 (4.6) 4 (0.4)  1 (0.1) 0 (0) 
Females 10 (1.0) 2 (3.1)  1 (1.5) 5 (0.5) 2 (3.1) 
 
DISCUSSION                                                                     
The presence of significant serum antibody to E. 
histolytica and T. gondii among HIV sero-positive 
patients in the study has further exposed these 
two parasitic organisms as possible opportunistic 
infections in HIV infected / AIDS patients as 
previously reported (1, 2). Medical practitioners 
in this region should focus attention on the 
diagnosis of these organisms and clinical 
management of infection with these organisms as 
well as other endemic diseases like malaria and 
tuberculosis that may interact or be opportunistic 
in HIV infected and AIDS patients.  
The significant titer value of 1:32 or more 
recorded in this study in HIV sero-positive as 
well as in HIV sero-negative patients is an 
indication of the presence of invasive E. 
histolytica. Clinical manifestations associated with 
E. histolytica infection could result in 
asymptomatic and symptomatic infection with or 
without tissue invasion. E. histolytica may remain 
a harmless commensal in its host or may become 
pathogenic due to certain factors not fully 
understood; however, immunosuppression had 
been described as a factor that could turn 
harmless commensal E. histolytica into a 
dangerously invasive one. Majority of infection 
with E. histolytica are asymptomatic and such 
individuals will have a negative or weak 
serologic response and will primarily pass cysts 
in their stools 38, 39. In one study, asymptomatic 
HIV-1 infected individuals with high anti-Eh titer 
were reported to be at risk of IA, perhaps as a 
result of exacerbation of subclinical amebiasis 
(27). In another study, the main presenting 
symptoms of IA were reported as fever, chronic 
diarrhea, and abdominal pain (29). 
Only 1.5% of the HIV sero-positive patients in the 
study had serum antibody to Schistosoma sp. 
infection as compared with 0.6% of HIV sero-
negative patients that had serum antibody. Both 
urogenital and intestinal schistosomiasis are 
chronic inflammatory disease caused by a water-
borne parasitic blood fluke with about 220 
million people infected in sub-Saharan Africa, 
and more people especially children at risk (17). 
The presence of Schistosoma sp. serum antibodies 
with titer value of 1:16 in only one HIV sero-
positive patients in this study does not exclude a 
possible interaction between Schistosoma sp. and 
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HIV in endemic areas like Nigeria since both 
agents co-inhabit the blood where they both 
cause pathological symptoms. Further studies are 
progressing to investigate the effect of one on the 
other in infected patients. Few of such studies 
that examined the interaction between 
Schistosoma sp. and HIV co-infection especially in 
areas where dual endemicity is most prevalent 
tried to understand the pathogenesis and 
immune responses in co-infection as well as 
clinical studies of responses to antiparasitic and 
antiretroviral drugs for HIV/AIDS disease 
progression (3, 17, 40). 
Indications for the presence of T. gondii infection 
was found in two patients that were sero-positive 
for HIV and one patient that was sero-negative 
for HIV with a significant titer value. In the 
diagnosis of T. gondii infection, a negative IgM 
indicates absence of infection in the past 6 
months while a combination of positive IgM and 
IgG titer indicates acute infection (41, 42, 43). A 
positive IgG test with a negative IgM indicates 
chronic infection (12). This result thus supports 
the presence of T. gondii infection in HIV 
infection in the area. A sero-prevalence of 58% 
was reported for Toxo-IgG antibodies among 
HIV patients without neurological complications 
in Lagos, Nigeria (44). Although more females 
than males in this study presented with serum 
antibodies to T. gondii infection, studies have 
shown that there is little or no difference in the 
prevalence of T. gondii infection between sexes 
(6). 
Limitation                                                                      
Limitation of this study includes the inability to 
investigate factors like education, nutrition, 
environmental and behavioral attitudes that can 
influence the rate differences between HIV 
infected and HIV non-infected patients in the 
study. Furthermore, serology positive tests for 
parasitic infections in the study could not be 
confirmed with more specific test due to limited 
resources. Another limitation is the low 
sensitivity and specificity of serological diagnosis 
of parasitic infections (45). In addition, sample 
sizes of HIV positive for uncommon parasites 
were very small. 
Recommendation                                              
Information on the prevalence of these diseases 
among HIV infected patients is scanty in the area; 
with a population of over 150 million and HIV 
prevalence of 3.1% among adults ages 15–49 
reported in 201246, more studies are required on 
these diseases by location in different part of the 
country.  
Conclusion                                                                        
We have therefore been able to further determine 
the sero-prevalence as well as demonstrate the 
presence of the three parasitic infections in the 
area most especially among HIV infected patients 
using serodiagnosis technique which is 
considered to be the most available and 
affordable routine method of diagnosing diseases 
like Toxoplasmosis in resource poor countries 
(37) and as well help guide therapeutic and 
management policies for infected patients in the 
area. 
Ethical considerations                                                                   
Ethical clearance                                                               
Ethical approval for the study was obtained from 
the Federal Ministry of Health Authority. 
Informed consent                                                           
Study objectives were explained to all 
participants. Participation was voluntary and 
confidentiality of study information was 
guaranteed. 
Competing interests                                                                                       
None 
Acknowledgement: The authors hereby 
acknowledge the contribution of late Professor 
Adetayo Folusho Fagbenro-Beyioku of the 
Department of Medical Microbiology & 
Parasitology, College of Medicine, University of 
Lagos, Idi-Araba, Lagos, Nigeria, who supervised 
the design of this study as well as the entire work 




1. Reed SL, Wessel DW, and Davis CE (1991). 
Entamoeba histolytica infection and AIDS. Am. 
J. Med. 90: 269-270. 
2. Luft BJ and Remington JS (1992). 
Toxoplasmosis encephalitis in AIDS. J. Clin. 
Infect. Dis. 15: 211-222. 
3. Fontanet AL, Woldermichael T, Sahlu GJ 
Messele T, Rinke de Wit W, Masho H, 
Yeneneh H, Coutinho RA, Van Lieshout L, 
Van Dam T. (2000). Epidemiology of HIV and 
Schistosoma mansoni infections among sugar 
estate residents in Ethiopia. Ann. Trop. Med. 
Parasitol. 94(2): 145-155. 
94 
 
4. Chaisson RE, Gallant JE, Keruly JC and 
Moore RD. (1998). Impact of opportunistic 
disease on survival in patients with HIV 
infection. AIDS. 12(1): 29-33. 
5. Nissapatorn, V. & Sawangjaroen, N. (2011). 
Parasitic infections in HIV infected 
individuals: Diagnostic & therapeutic 
challenges. The Indian J. Med. 
Research, 134(6), 878. 
6. Emerson G (1981).Toxoplasmosis: A treatable 
neurologic disease in the immunologically 
compromised patient. Pediatrics. 67: 653-655. 
7. Nissapatorn, V., A. Kamarulzaman, I. Init, L. 
H. Tan, M. Rohela, A. Norliza, L. L. Chan, H. 
M. Latt, A. K. Anuar, and K. F. Quek.(2002) 
"Seroepidemiology of toxoplasmosis among 
HIV-infected patients and healthy blood 
donors." The Med. J. of Malaysia 57(3): 304. 
8. Doudou Y, Renaud P, Coralie L, Jacqueline 
F, Hypolite S, Hypolite M, Patrick 
M, Andreia Ida L, Van Sprundel M, Marleen 
B, Van Geertruyden JP, Pascal L.(2014). 
Toxoplasmosis among pregnant women: 
high seroprevalence and risk factors in 
Kinshasa, Democratic Republic of Congo. 
Asian Pac J Trop Biomed. 2014 Jan; 4(1):69-74. 
9. Alayande, M. O., Edungbola, L. D., Fabiyi, J. 
P., Awosan, K. I., Babatunde, S. K., Suleiman, 
A. I., & Idowu, D. (2012). Seroprevalence of 
Toxoplasma infection in stored sera of HIV 
individual in Sokoto, Nigeria. African Journal 
of Microbiology Research, 6(5), 972-975. 
10. Amuta, E. U., Amali, O., Jacob, S. E., & 
Houmsou, R. S. (2013). Toxoplasma gondii 
IgG antibodies in HIV/AIDS patients 
attending hospitals in Makurdi metropolis, 
Benue state, Nigeria. International Journal of 
Medicine and Biomedical Research, 1(3), 186-192. 
11. Furrer, H., Opravil, M., Bernasconi, E., 
Telenti, A., & Egger, M. (2000). Stopping 
primary prophylaxis in HIV-1-infected 
patients at high risk of toxoplasma 
encephalitis. The Lancet. 355(9222), 2217-
2218. 
12. Okwuzu, J. O., Odunukwe, N. N., Ezechi, O. 
C., Gbajabiamila, T. A., Musa, A. Z., Ezeobi, 
P. M., ... & Otubanjo, A. O. (2014). Toxoplasma 
gondii Infection in HIV/AIDS: Prevalence 
and Risk Factors. African Journal of Clinical 
and Experimental Microbiology, 15(2), 97-102. 
13. Ogoina, D., Onyemelukwe, G. C., Musa, B. 
O., & Obiako, R. O. (2013). Seroprevalence of 
IgM and IgG Antibodies to Toxoplasma 
infection in healthy and HIV-positive adults 
from Northern Nigeria. The Journal of Infection 
in Developing Countries, 7(05), 398-403. 
14. Mafe MA (1997). The diagnosis potential of 
three indirect tests for urinary 
schistosomiasis in Nigeria. Acta Tropica. 68: 
277-284. 
15. Ejezie GC, Gemade EI and Utselo SJ (1989). 
The schistosomiasis problem in Nigeria 
(Review). J. Hyg Epiemiol Microbiol 
Immunol. 33(2): 169-179. 
16. Adewunmi CO. (1993). Schistosomiasis and 
intestinal parasites in rural villages in South 
West Nigeria: an indication for expanded 
programme on drug distribution and 
integrated control programme in Nigeria. 
Trop. Med. Parasitol. 44(3):177-180. 
17. Bustinduy, A., King, C., Scott, J., Appleton, S., 
Sousa-Figueiredo, J. C., Betson, M., & 
Stothard, J. R. (2014). HIV and 
schistosomiasis co-infection in African 
children. The Lancet infectious diseases. 
18. Downs, J. A., van Dam, G. J., Changalucha, J. 
M., Corstjens, P. L., Peck, R. N., Claudia, J., ... 
& Fitzgerald, D. W. (2012). Association of 
schistosomiasis and HIV infection in 
Tanzania. The American journal of tropical 
medicine and hygiene, 87(5), 868-873. 
19. Mazigo, H. D., Dunne, D. W., Wilson, S., 
Kinung’hi, S. M., de Moira, A. P., Jones, F. M., 
& Nuwaha, F. (2014). Co-infection with 
Schistosoma mansoni and Human 
Immunodeficiency Virus-1 (HIV-1) among 
residents of fishing villages of north-western 
Tanzania. Parasites & vectors, 7(1). 
20. Secor, W. E. (2006). Interactions between 
schistosomiasis and infection with 
HIV‐1. Parasite Immunology, 28(11), 597-603. 
21. Secor, W. E. (2012). The effects of 
schistosomiasis on HIV/AIDS infection, 
progression and transmission. Current 
Opinion in HIV and AIDS, 7(3), 254-259. 
22. Sergeaunt PG and Williams JE (1978). 
Electrophoretic isoenzyme patterns of 
Entamoeba histolytica and Entamoeba coli. 
Trans. Roy. Soc.Trop. Med. Hyg. 72: 164-166. 
23. Ortner S, Clark CG, Binder M, Scheiner O, 
Wiedermann G and Duchene M (1997). 
Molecular biology of the hexokinase 
isoenzyme pattern that distinguishes 
pathogenic Entamoeba histolytica from non–
pathogenic Entamoeba dispar. Mol. Biochem. 
Parasitol. 86: 85-94. 
95 
 
24. Diamond LS and Clerk CG (1994). A 
redescription of Entamoeba histolytica 
Schaudinn, 1903 (Emended Walker, 1911) 
separating it from Entamoeba dispar Brumpt, 
1925. J. Eukaryot. Microbiol. 40: 340-344. 
25. Clark CG and Diamond LS (1993). Entamoeba 
histolytica an explanation for the reported 
conversion of ‘nonpathogenic’ amoebae to 
the ‘pathogenic’ form. Expt. Parasitol. 77: 
456-460. 
26. Lowther SA, Dworkin MS, Hanson DI (2000). 
Entamoeba histolytica/Entamoeba dispar 
infection in human immunodeficiency virus 
infected patients in the United States. Clin. 
Infect. Dis. 30: 955-999. 
27. Watanabe, K., Aoki, T., Nagata, N., Tanuma, 
J., Kikuchi, Y., Oka, S., & Gatanaga, H. (2013). 
Clinical significance of high anti-Entamoeba 
histolytica antibody titer in asymptomatic 
HIV-1-infected individuals. Journal of 
Infectious Diseases, jit815. 
28. Watanabe, K., Gatanaga, H., Escueta-de 
Cadiz, A., Tanuma, J., Nozaki, T., & Oka, S. 
(2011). Amebiasis in HIV-1-infected Japanese 
men: clinical features and response to 
therapy. PLoS Neglected Tropical Diseases, 5(9), 
e1318. 
29. Hung, C. C., Chen, P. J., Hsieh, S. M., Wong, 
J. M., Fang, C. T., Chang, S. C., & Chen, M. Y. 
(1999). Invasive amoebiasis: an emerging 
parasitic disease in patients infected with 
HIV in an area endemic for amoebic 
infection. Aids, 13(17), 2421-2428. 
30. Lo, Y. C., Ji, D. D., & Hung, C. C. (2014). 
Prevalent and Incident HIV Diagnoses 
among Entamoeba histolytica-Infected Adult 
Males: A Changing Epidemiology Associated 
with Sexual Transmission—Taiwan, 2006–
2013. PLoS Neglected Tropical Diseases, 8(10), 
e3222. 
31. Sanyaolu, A. O., Oyibo, W. A., Fagbenro-
Beyioku, A. F., Gbadegeshin, A. H., & 
Iriemenam, N. C. (2011). Comparative study 
of entero-parasitic infections among HIV 
sero-positive and sero-negative patients in 
Lagos, Nigeria. Acta Tropica, 120(3), 268-272. 
32. Biokit USA (Toxocell IHA). Comparative 
studies of Toxocell IHA with IFA and direct 
agglutiantion. Q.C. Department, Biokit, S.A. 
in: Test for the determination of total 
antibodies against Toxoplasma gondii. 
www.biokitusa.com/pdfs/3000614512.pdf  
33. Naot Y and Remington J. (1980). An enzyme 
linked immunosorbent assay for detection of 
IgM antibodies to Toxoplasma gondii: use for 
diagnosis of acute acquired Toxoplasmosis. J. 
Infect. Dis. 142(5): 757-766. 
34. Hossain A, Bolbol AS, Chowdhury MN, 
Bakir TM (1989). Indirect haemagglutination 
(IHA) test in the serodiagnosis of amebiasis. 
J. Hyg. Epidemiol. Microbiol. Immunol. 33 
(1): 91-97. 
35. Feldmeier H and Poggensee (1993). 
Diagnosic techniques in schistosomiasis 
control. A review. Acta Tropica. 52(4): 205-
220. 
36. Yaneza A and Kumari P. (1994). Prevalence 
of Toxoplasma antibodies in blood donors in 
AL-HASSA. Annals of Saudi Medicine. 14(3): 
1-3. 
37. Fotedar R, Stark D, Beebe N, Marriott D, Ellis 
J, Harkness J. (2007). Laboratory Diagnostic 
Techniques for Entamoeba Species. Clin. 
Microbiol. Rev. 20(3): 511. 
38. Espinosa-Cantellano M and Martinez-Palomo 
A. (2000). Pathogenesis of intestinal 
amebiasis from molecules to disease. Clin. 
Microbiol. Rev. 13:318-331. 
39. Huston CD and Petri WA (1999). Amebiasis 
clinical implications of the recognition of 
Entamoeba dispar. Curr. Infect. Dis. Rep. 1: 
441-447. 
40. Karanja DMS, Colley DG, Nahlen BL, Ouma 
JH and Secor WE (1997). Studies on 
Schistosomiasis in western Kenya 1. Evidence 
for immune-facilitated excretion of 
schistosome eggs from patients with 
Scistosoma mansoni and HIV co-infections. 
Ann J Trop Med Hyg. 56: 515-521. 
41. Decoster A and Lecolier B (1996). Bicentric 
evaluation of Access Toxo immunoglobulin 
M (IgM) and IgG assays and IMx Toxo IgM 
and IgG assays and comparison with Platelia 
Toxo IgM and IgG assays. J. Clin. Microbiol. 
34: 1606-1609. 
42. Liesenfield OC, Press JG, Montoya R, Gill JL, 
Isaac-Renton KH, Remington JS. (1997). 
False-positive results in immunoglobulin M 
(IgM) toxoplasma antibody tests and 
importance of confirmatory testing-the 
Platelia Toxo IgM test. J. Clin Microbiol. 35: 
174-178. 
43. Liu X, Turner BP, Peyton CE, Reisner BS, 
Okorodudu AO, Mohammad AA, Hankins 
GD, Weissfeld AS, Petersen JR. (2000). 
Prospective study of IgM to Toxoplasma gondii 
on Beckman Coulter’s AccessTM 
immunoassay system and comparison with 
96 
 
Zeus ELISA and Gull IFA assays. Diagn. 
Microbial. Infect. Disc. 36: 237-239. 
44. Osunkalu VO, Akanmu SA, Ofomah NJ, 
Onyiaorah IV, Adediran AA, Akinde RO 
Onwuezobe IA (2011). Seroprevalence of 
Toxoplasma gondii IgG antibody in HIV 
infected patients at the Lagos University 
Teaching Hospital. HIV/AIDS-Research and 
Palliative Care. 3:101-105. 
45. El-Adawi, A. I., El-Hoda, A. N., Dahawi, H. 
S., & El-Naggar, S. M. (1994). Reliability of 
IHA Test as a Diagnostic Tool of Some 
Parasitic Infections. Med. J. Cairo Univ., Vol. 
62, No.1 March (Suppl.): 1-4. 
46. CIA World Factbook (2012). HIV/AIDS - 




Accessed January 9, 2015. 
  
